Beta Bionics Files 8-K on Financials
Ticker: BBNX · Form: 8-K · Filed: May 6, 2025 · CIK: 1674632
| Field | Detail |
|---|---|
| Company | Beta Bionics, Inc. (BBNX) |
| Form Type | 8-K |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Beta Bionics dropped an 8-K detailing its financial condition and results. Check it out.
AI Summary
Beta Bionics, Inc. filed an 8-K on May 6, 2025, reporting on its Results of Operations and Financial Condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 11 Hughes, Irvine, California.
Why It Matters
This filing provides investors with crucial updates on Beta Bionics' financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Beta Bionics, Inc. (company) — Registrant
- May 6, 2025 (date) — Date of earliest event reported
- 11 Hughes, Irvine, California 92618 (location) — Principal Executive Offices
- 47-5386878 (company_id) — I.R.S. Employer Identification No.
- 001-42491 (company_id) — Commission File Number
FAQ
What specific financial information is being reported in this 8-K?
The 8-K reports on Beta Bionics, Inc.'s Results of Operations and Financial Condition, and includes Financial Statements and Exhibits.
When was this 8-K filing submitted?
The filing was submitted on May 6, 2025.
What is the principal business address of Beta Bionics, Inc.?
The principal executive offices are located at 11 Hughes, Irvine, California 92618.
What is the Commission File Number for Beta Bionics, Inc.?
The Commission File Number is 001-42491.
What is the I.R.S. Employer Identification Number for Beta Bionics, Inc.?
The I.R.S. Employer Identification Number is 47-5386878.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding Beta Bionics, Inc. (BBNX).